The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex complicated synthetic process. Early routes focused on amino acid chain section coupling, utilizing https://rsacsnj006715.blog-eye.com/41056633/production-and-investigation-applications-of-retatrutide